NHS health checks: an update on the debate and program implementation in England. by Abdalrahman, B & Soljak, M
LWW/JACM JACM-D-14-00053 November 21, 2014 18:46
J Ambulatory Care Manage
Vol. 38, No. 1, pp. 5–9
Copyright C© 2015 Wolters Kluwer Health | Lippincott Williams & Wilkins
NHS Health Checks
An Update on the Debate and
Program Implementation in England
Bayad Abdalrahman, MPH; Michael Soljak, PhD
Abstract: Cardiovascular disease is the leading cause of mortality and morbidity worldwide. In
England, the government has adopted a population-wide prevention program for cardiovascular
disease, the NHS Health Check program. The program has sparked controversies over the evidence
base and feasibility of implementation. We aim to provide an update on the debate and program
implementation. In conclusion, the evidence base for the NHSHealth Check program has a number
of uncertainties and program delivery has been suboptimal. It is important to continue monitoring
and evaluating the program to provide the evidence base for future policy direction. Key words:
cardiovascular disease, health check, public health, primary prevention
C ARDIOVASCULAR DISEASE (CVD) is themain cause of death and disability in
many developed and developing countries
(Krishnamurthi et al., 2013; Moran et al.,
2014). Over recent years, the focus of health
care systems has shifted from treatment of es-
tablished disease to a primary prevention ap-
proach (Department of Health, 2008a, 2010).
In the United States, the Million Hearts
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Initiative aims to prevent 1 million heart
attacks and strokes over the next 5 years
(Frieden & Berwick, 2011). In 2008, the En-
glish Government announced a population-
wide program, the National Health Service
(NHS) Health Check program, to reduce the
burden of CVD and associated health inequal-
ities (Department of Health, 2008b). The pro-
gram is based on prevention and early detec-
tion of individuals at high risk of developing
CVD. The NHS Health Check program cov-
ers both CVD risk assessment and risk man-
agement in a primary care–led setting. The
elements of the program are based on best
available evidence from the World Health Or-
ganization (2007, 2008), the National Insti-
tute for Health and Care Excellence (2010),
and the National Screening Committee (UK
National Screening Committee and University
of Leicester, 2012).
The details of the establishment of the pro-
gram are described elsewhere (Dalton & Sol-
jak, 2012; Department of Health, 2008a). This
article aims to provide an update on the im-
plementation of the NHS Health Check pro-
gram in England and the often vigorous debate
about the program.
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THE EVIDENCE CONTROVERSY
There is growing debate about both the
clinical effectiveness and cost-effectiveness
of systematic health checks. Critics of the
program cite a meta-analysis by Krogsbøll
et al. (2012), who conducted a Cochrane sys-
tematic review andmeta-analysis of the effects
of randomized controlled trials. They com-
pared health checks with no health checks
in adult populations unselected for disease or
risk factors and focused on the effects on mor-
tality. The authors defined health checks as
screening general populations for more than
one disease or risk factor in more than one or-
gan system. Krogsbøll et al. found that nine tri-
als recorded the total mortality outcome and
the risk ratio for death was 0.99 (95% con-
fidence interval, 0.95-1.03). Eight trials pro-
vided data on CVD-associated mortality, with
the estimated risk ratio of 1.03 (95% confi-
dence interval, 0.91-1.17). The authors con-
cluded that general health checks did not re-
duce totalmortality or cause-specificmortality
from CVD and cancer. Krogsbøll et al. (2013)
followed their review with a call to abandon
the NHS Health Check program in England).
In England, this sparked a number of dif-
ferent responses from Public Health England
(PHE) (2013b), researchers, and health care
professionals. The President of the Faculty
of Public Health stated that the NHS Health
Check program can be beneficial, particularly
for people in deprived areas (Faculty of Pub-
lic Health, 2013). Some researchers argued
that the conclusion of Krogsbøll et al. had
limited relevance to the NHS Health Check
program, because the most recent study in-
cluded started in 1999, and so preceded the
statin era, and called for a robust evaluation
of the program based on patient-level primary
care data in terms of CVD outcome (Majeed
& Banarsee, 2013; Soljak, 2013; Soljak et al.,
2013). On the contrary, the chair of the Royal
College of General Practitioners backed the
Nordic researchers’ views to scrap the NHS
Health Check program (Price, 2013).
The evidence debate rumbles on. Si et al
(2014) published a systematic review fo-
cusing specifically on general practice-based
health checks, which showed that they are
associated with statistically significant, albeit
clinically small, improvements in surrogate
outcome control, especially among high-risk
patients. Most of the included studies were
not designed to assess mortality. Most re-
cently, a Danish controlled trial of counseling
interventions found no effect on CVD inci-
dence or mortality after 10 years, but it did
not include any data on primary care man-
agement or prescribed drugs over the study
period.
IMPLEMENTATION ISSUES
Most Health Checks are conducted by gen-
eral practices, usually by practice nurses and
health care assistants, although alternative ser-
vice providers and pharmacists are deliver-
ing them in some areas. In 2013-2014, 18.5%
of the 5-year (2013-2018) eligible population
was offered an Health Check intervention
compared with 16.5% in 2012-2013, but of
the 15 million target population, 12 million
of the population are still outstanding (PHE,
2014). Meanwhile, general practices are strug-
gling with higher patient demand in the face
of stagnant NHS funding because of the par-
lous state of UK public finances. However, the
equivalent New Zealand program shows that
75% coverage can be achieved (New Zealand
Ministry of Health, 2013).
There are also concerns over the 49% invita-
tion uptake rate, which couldwiden health in-
equalities (House of Commons, 2014). As part
of NHS reforms, responsibility for delivering
Health Checks was transferred in 2013 from
the NHS to local government, which slowed
progress, but PHE is supporting local authori-
ties to promote uptake (PHE, 2013b).
On the contrary, a local UK study showed
that program uptake is high in a deprived and
culturally diverse area, with 44.8% of high-risk
patients attending a Health Check program
(Dalton et al., 2011). Furthermore, Artac et al.
(2013a) conducted a cross-sectional study of
Health Check coverage in England and found
that the uptake is significantly higher in de-
prived communities.
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COST-EFFECTIVENESS
The economic costs and benefits of the
program are based on modeling work by
PHE. The model estimated that the savings
to the NHS budget nationally are around
£57 million over 4 years, rising to £176 mil-
lion over a 15-year period. It is estimated that
the program will pay for itself after 20 years
as well as having delivered substantial health
benefits (PHE, 2013a). The PHE Health Check
action plan stated that Health Checks could
annually prevent 1600 heart attacks and save
650 lives; prevent 4000 people from develop-
ing diabetes; and detect at least 20 000 cases
of diabetes or kidney disease earlier. The esti-
mated cost per quality-adjusted life year was
approximately £3000 (Department of Health,
2008a).
Researchers using the Archimedes simula-
tion model published a mathematical model-
ing study that estimated the cost-effectiveness
of several health check strategies compared
with a control scenario in six European
countries: France, United Kingdom, Poland,
Germany, Denmark, and Italy (Schuetz
et al., 2013). The model showed that in the
United Kingdom, for every 1000 individuals
who undertake the base-case health check,
13.2 major CVD events and 9.6 microvascu-
lar complications (blindness, chronic kidney
disease, end-stage renal disease, renal death,
foot ulcer, or amputation) could be averted.
In the United Kingdom, the analysis at 30
years’ follow-up showed the cost per quality-
adjusted life year to be €2426, and it is cost
saving if the program targeted the top quar-
tile of risk or those with obesity. The re-
searchers concluded that the Health Check
program would be cost-effective in all 6 coun-
tries. This analysis echoes the original PHE
modeling work and provides further support
to the program.
The case for primary prevention of CVD
with statins was made by a recent Cochrane
review (Taylor et al., 2013). The authors as-
sessed the effects, both harms and benefits,
of statins in people with no history of CVD.
It concluded that all-cause mortality, major
vascular events, and revascularizations were
reduced and there was no excess of adverse
events among people without evidence of
CVD treated with statins. Furthermore, in
their new, equally controversial guidelines,
the American College of Cardiology and the
American Heart Association Task Force has
lowered the threshold of statin treatment for
patients aged 40 to 75 years from 20% or
higher 10-year CVD risk to 7.5% or higher
(Stone et al., 2013). In the United Kingdom,
there has been a similar proposal by NICE
to reduce the 10-year CVD risk threshold for
statin treatment to 10% or higher rather than
20% (National Institute for Health and Care
Excellence, 2014).
The systematic approach to prescribe
statins through the NHS Health Check pro-
gram is likely to contribute to a substantial
fall in CVD events. A local evaluation of the
English program showed large increases in
appropriate statin prescribing after a Health
Check (Artac et al., 2013b). However, a group
of prominent academics has written to NICE
expressing concern about medicalization of
healthy individuals, true levels of adverse
events, hidden data, industry bias, loss of pro-
fessional confidence, and NICE experts’ con-
flicts of interest (Wise, 2014). While the cur-
rent government has continued the Health
Check program, it has been slow to address
the wider agenda, such as greater regulation
of the food industry.
CONCLUSION
The need to prevent CVD through both
broader public health interventions and pri-
mary care–based programs is pressing despite
concerns about the evidence base. The con-
troversies around the NHS Health Check pro-
gram should not deter the United Kingdom
from combating CVD through its highly or-
ganized primary care services. There is no
doubt that more work is needed to moni-
tor and evaluate the effectiveness of the pro-
gram and to find effective approaches to
present risk and support changes in health
behaviors.
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